Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Acta Diabetologica
Metadata
Title
Bone mineral mass in overweight and obese children: diminished or enhanced?
Authors
K. J. Ellis
R. J. Shypailo
W. W. Wong
S. A. Abrams
Publication date
01-10-2003
Publisher
Springer-Verlag
Published in
Acta Diabetologica / Issue Special Issue 1/2003
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-003-0085-z

Other articles of this Special Issue 1/2003

Acta Diabetologica 1/2003 Go to the issue

ORIGINAL

Pencil-beam versus fan-beam dual-energy X-ray absorptiometry comparisons across four systems: appendicular lean soft tissue

ORIGINAL

The prediction of basal metabolic rate in young adult, severely obese patients using single-frequency bioimpedance analysis

ORIGINAL

BMI inaccurately reflects total body and abdominal fat in Tongans

ORIGINAL

Prevalence of low fat-free mass index and high and very high body fat mass index following lung transplantation

ORIGINAL

Short- and long-term evolution of body composition in 1,389 obese outpatients following a very low calorie diet (Pro’gram18 VLCD)

ORIGINAL

Some aspects of measuring levels of potassium in the brain

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits